Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210067324> ?p ?o ?g. }
- W3210067324 abstract "Unlike other biologic agents for rheumatoid arthritis (RA) that are administered at regular intervals even without flare, rituximab can be administered according to the timing of retreatment determined by the physician. Recently, there has been a tendency to prefer on-demand administration for disease flares rather than regular retreatment. We aimed to investigate the retreatment patterns of rituximab in patients with RA and to identify factors associated with extension of the time interval between retreatment courses. This study included RA patients on rituximab treatment who were enrolled in the Korean Rheumatology Biologics registry (KOBIO) or treated at Ajou University Hospital. Previous or current concomitant conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs), corticosteroids, number of previous biologic agents, withdrawal, and time intervals of rituximab retreatment were collected. In case of treatment failure, the reasons such as lack of efficacy, adverse events, and others, were also identified. A total of 82 patients were enrolled. The mean follow-up period from the first cycle of rituximab was 46.1 months, and the mean interval between the retreatment courses was 16.3 months. The persistent rates of rituximab after 5 years was 72.4%. Concomitant use of at least two csDMARDs (β = 4.672; 95% CI: 0.089-9.255, p = 0.046) and concomitant use of corticosteroids (β = 7.602; 95% CI: 0.924-14.28, p = 0.026) were independent factors for extending the time interval between the retreatment courses. In conclusion, RA patients treated with rituximab in Korea show high persistence rates. Concomitant use of two or more csDMARDs and concomitant use of corticosteroids with rituximab are associating factors of extending the retreatment time interval. These findings should be considered when selecting rituximab as a treatment for patients with RA." @default.
- W3210067324 created "2021-11-08" @default.
- W3210067324 creator A5024934467 @default.
- W3210067324 creator A5039404576 @default.
- W3210067324 creator A5064212873 @default.
- W3210067324 creator A5083253699 @default.
- W3210067324 creator A5091554389 @default.
- W3210067324 date "2021-10-28" @default.
- W3210067324 modified "2023-10-16" @default.
- W3210067324 title "Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis" @default.
- W3210067324 cites W1613595294 @default.
- W3210067324 cites W1879199789 @default.
- W3210067324 cites W1951218190 @default.
- W3210067324 cites W1965723104 @default.
- W3210067324 cites W2008278861 @default.
- W3210067324 cites W2022145966 @default.
- W3210067324 cites W2023597726 @default.
- W3210067324 cites W2024644107 @default.
- W3210067324 cites W2049872026 @default.
- W3210067324 cites W2063811338 @default.
- W3210067324 cites W2113482445 @default.
- W3210067324 cites W2118463772 @default.
- W3210067324 cites W2118994799 @default.
- W3210067324 cites W2126046176 @default.
- W3210067324 cites W2128952811 @default.
- W3210067324 cites W2130631271 @default.
- W3210067324 cites W2132841358 @default.
- W3210067324 cites W2135776438 @default.
- W3210067324 cites W2135856630 @default.
- W3210067324 cites W2143214745 @default.
- W3210067324 cites W2148009861 @default.
- W3210067324 cites W2149524733 @default.
- W3210067324 cites W2152348310 @default.
- W3210067324 cites W2152676410 @default.
- W3210067324 cites W2338241123 @default.
- W3210067324 cites W2400974386 @default.
- W3210067324 cites W2411832526 @default.
- W3210067324 cites W2516968938 @default.
- W3210067324 cites W2766707943 @default.
- W3210067324 cites W2783081258 @default.
- W3210067324 cites W2792050029 @default.
- W3210067324 cites W2800778103 @default.
- W3210067324 cites W2884312935 @default.
- W3210067324 cites W2895590824 @default.
- W3210067324 cites W2937184143 @default.
- W3210067324 cites W2966423636 @default.
- W3210067324 cites W2973443323 @default.
- W3210067324 cites W3008372023 @default.
- W3210067324 cites W3014146563 @default.
- W3210067324 cites W3024766246 @default.
- W3210067324 cites W3118513959 @default.
- W3210067324 cites W3136566594 @default.
- W3210067324 doi "https://doi.org/10.3389/fmed.2021.765535" @default.
- W3210067324 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8581042" @default.
- W3210067324 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34778324" @default.
- W3210067324 hasPublicationYear "2021" @default.
- W3210067324 type Work @default.
- W3210067324 sameAs 3210067324 @default.
- W3210067324 citedByCount "2" @default.
- W3210067324 countsByYear W32100673242022 @default.
- W3210067324 crossrefType "journal-article" @default.
- W3210067324 hasAuthorship W3210067324A5024934467 @default.
- W3210067324 hasAuthorship W3210067324A5039404576 @default.
- W3210067324 hasAuthorship W3210067324A5064212873 @default.
- W3210067324 hasAuthorship W3210067324A5083253699 @default.
- W3210067324 hasAuthorship W3210067324A5091554389 @default.
- W3210067324 hasBestOaLocation W32100673241 @default.
- W3210067324 hasConcept C126322002 @default.
- W3210067324 hasConcept C141071460 @default.
- W3210067324 hasConcept C197934379 @default.
- W3210067324 hasConcept C198451711 @default.
- W3210067324 hasConcept C2777575956 @default.
- W3210067324 hasConcept C2779338263 @default.
- W3210067324 hasConcept C2779384505 @default.
- W3210067324 hasConcept C2780653079 @default.
- W3210067324 hasConcept C71924100 @default.
- W3210067324 hasConceptScore W3210067324C126322002 @default.
- W3210067324 hasConceptScore W3210067324C141071460 @default.
- W3210067324 hasConceptScore W3210067324C197934379 @default.
- W3210067324 hasConceptScore W3210067324C198451711 @default.
- W3210067324 hasConceptScore W3210067324C2777575956 @default.
- W3210067324 hasConceptScore W3210067324C2779338263 @default.
- W3210067324 hasConceptScore W3210067324C2779384505 @default.
- W3210067324 hasConceptScore W3210067324C2780653079 @default.
- W3210067324 hasConceptScore W3210067324C71924100 @default.
- W3210067324 hasLocation W32100673241 @default.
- W3210067324 hasLocation W32100673242 @default.
- W3210067324 hasLocation W32100673243 @default.
- W3210067324 hasLocation W32100673244 @default.
- W3210067324 hasOpenAccess W3210067324 @default.
- W3210067324 hasPrimaryLocation W32100673241 @default.
- W3210067324 hasRelatedWork W2031753437 @default.
- W3210067324 hasRelatedWork W2091629131 @default.
- W3210067324 hasRelatedWork W2119875305 @default.
- W3210067324 hasRelatedWork W2143143301 @default.
- W3210067324 hasRelatedWork W2244855815 @default.
- W3210067324 hasRelatedWork W2278084370 @default.
- W3210067324 hasRelatedWork W2801221612 @default.
- W3210067324 hasRelatedWork W3178040701 @default.
- W3210067324 hasRelatedWork W562161591 @default.